University of California San Francisco

Successful treatment of mucous membrane pemphigoid with bortezomib.

Saeed L, Schmidt TH, Gensler LS, Gross AJ, Fox LP, Scharschmidt TC, Gaensler K, Naik H, Rosenblum MA, Shinkai K PMID: 29387757

Successful treatment of mucous membrane pemphigoid with bortezomib.

Saeed L, Schmidt TH, Gensler LS, Gross AJ, Fox LP, Scharschmidt TC, Gaensler K, Naik H, Rosenblum MA, Shinkai K PMID: 29387757

Successful treatment of mucous membrane pemphigoid with bortezomib.

Saeed L, Schmidt TH, Gensler LS, Gross AJ, Fox LP, Scharschmidt TC, Gaensler K, Naik H, Rosenblum MA, Shinkai K PMID: 29387757

Successful treatment of mucous membrane pemphigoid with bortezomib.

Saeed L, Schmidt TH, Gensler LS, Gross AJ, Fox LP, Scharschmidt TC, Gaensler K, Naik H, Rosenblum MA, Shinkai K PMID: 29387757

Characteristics of research tracks in dermatology residency programs: a national survey.

Narala S, Loh T, Shinkai K, Paravar T PMID: 29447650

Dermatology Medical Education: A Multicenter Survey Study of the Undergraduate Perspective of the Dermatology Clinical Clerkship.

Davari P, Millsop JW, Johnson MAN, Takahashi SR, Peng DH, Badger J, Bahr BA, Shinkai K, Li CS, Fazel N PMID: 29447648

Reply to: Comment on "Serious infections among a large cohort of subjects with systemically treated psoriasis".

Dobry AS, Quesenberry CP, Asgari MM PMID: 29247684

HDAC inhibition potentiates immunotherapy in triple negative breast cancer.

Terranova-Barberio M, Thomas S, Ali N, Pawlowska N, Park J, Krings G, Rosenblum MD, Budillon A, Munster PN PMID: 29371976

Merkel cell carcinoma: An update and review: Current and future therapy.

Tello TL, Coggshall K, Yom SS, Yu SS PMID: 29229573

Merkel cell carcinoma: An update and review: Pathogenesis, diagnosis, and staging.

Coggshall K, Tello TL, North JP, Yu SS PMID: 29229574